By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Transition Therapeutics Inc. 

415 Yonge Street
Suite 1103
Toronto  Ontario  M5B2E7  Canada
Phone: 416-260-7770 Fax: 416-260-2886


SEARCH JOBS








Company News
Transition Therapeutics Inc. (TTH.TO) Announces Results Of Clinical Study Of ELND005 In Agitation And Aggression In Patients With Alzheimer's Disease 6/24/2015 6:41:13 AM
Transition Therapeutics Inc. (TTH.TO) Appoints Carl Damiani As President 6/16/2015 9:30:11 AM
Transition Therapeutics Inc. (TTH.TO) To Present At The Jefferies and Co. 2015 Healthcare Conference 5/26/2015 6:59:15 AM
Transition Therapeutics Inc. (TTH.TO) Announces Third Quarter Fiscal 2015 Financial Results 5/13/2015 6:55:29 AM
Transition Therapeutics Inc. (TTH.TO) To Hold Conference Call On Third Quarter Fiscal 2015 Financial Results On Tuesday, May 12th, At 4:30 P.M. EST 5/8/2015 6:53:42 AM
Transition Therapeutics Inc. (TTH.TO) In-Licenses Phase 2 Drug Candidate From Eli Lilly (LLY) 5/6/2015 6:26:42 AM
Transition Therapeutics Inc. (TTH.TO) Announces Results From Phase 1 AME & Renal Clearance Clinical Studies Of Neuropsychiatric Drug Candidate ELND005 3/26/2015 6:26:21 AM
Transition Therapeutics Inc. (TTH.TO) Announces Enrolment Completion Of ELND005 Phase 2 Clinical Study In Agitation And Aggression In Patients With Alzheimer's Disease 3/2/2015 6:40:41 AM
Transition Therapeutics Inc. (TTH.TO) To Present At The Cowen and Company 35th Annual Healthcare Conference 2/19/2015 11:56:58 AM
Transition Therapeutics Inc. (TTH.TO) Announces Closing Of Public Offering Of US$23 Million Of Common Shares 2/18/2015 2:37:13 PM
12345678910...
//-->